These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 33639198)

  • 21. Mechanisms of coronavirus infectious disease 2019-related neurologic diseases.
    Klein RS
    Curr Opin Neurol; 2022 Jun; 35(3):392-398. PubMed ID: 35283461
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of β-Blockers on the Sympathetic and Cytokines Storms in Covid-19.
    Al-Kuraishy HM; Al-Gareeb AI; Mostafa-Hedeab G; Kasozi KI; Zirintunda G; Aslam A; Allahyani M; Welburn SC; Batiha GE
    Front Immunol; 2021; 12():749291. PubMed ID: 34867978
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses.
    Artese A; Svicher V; Costa G; Salpini R; Di Maio VC; Alkhatib M; Ambrosio FA; Santoro MM; Assaraf YG; Alcaro S; Ceccherini-Silberstein F
    Drug Resist Updat; 2020 Dec; 53():100721. PubMed ID: 33132205
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Perturbed Lipid Metabolism Transduction Pathways in SARS-CoV-2 Infection and Their Possible Treating Nutraceuticals.
    Shukla A; Singh A; Tripathi S
    J Am Nutr Assoc; 2024; 43(7):614-626. PubMed ID: 38805016
    [TBL] [Abstract][Full Text] [Related]  

  • 25. COVID-19 and cognitive impairment: neuroinvasive and blood‒brain barrier dysfunction.
    Chen Y; Yang W; Chen F; Cui L
    J Neuroinflammation; 2022 Sep; 19(1):222. PubMed ID: 36071466
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence of central nervous system infection and neuroinvasive routes, as well as neurological involvement, in the lethality of SARS-CoV-2 infection.
    Liu JM; Tan BH; Wu S; Gui Y; Suo JL; Li YC
    J Med Virol; 2021 Mar; 93(3):1304-1313. PubMed ID: 33002209
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SARS-CoV-2 induces blood-brain barrier and choroid plexus barrier impairments and vascular inflammation in mice.
    Qiao H; Deng X; Qiu L; Qu Y; Chiu Y; Chen F; Xia S; Muenzel C; Ge T; Zhang Z; Song P; Bonnin A; Zhao Z; Yuan W
    J Med Virol; 2024 May; 96(5):e29671. PubMed ID: 38747003
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comprehensive review of COVID-19 biology, diagnostics, therapeutics, and disease impacting the central nervous system.
    Williams A; Branscome H; Khatkar P; Mensah GA; Al Sharif S; Pinto DO; DeMarino C; Kashanchi F
    J Neurovirol; 2021 Oct; 27(5):667-690. PubMed ID: 34581996
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Manifestations and mechanisms of central nervous system damage caused by SARS-CoV-2.
    Yang F; Zhao H; Liu H; Wu X; Li Y
    Brain Res Bull; 2021 Dec; 177():155-163. PubMed ID: 34571039
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Severe Acute Respiratory Syndrome Coronavirus 2 Impact on the Central Nervous System: Are Astrocytes and Microglia Main Players or Merely Bystanders?
    Murta V; Villarreal A; Ramos AJ
    ASN Neuro; 2020; 12():1759091420954960. PubMed ID: 32878468
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Understanding the Role of Blood Vessels in the Neurologic Manifestations of Coronavirus Disease 2019 (COVID-19).
    Whitmore HAB; Kim LA
    Am J Pathol; 2021 Nov; 191(11):1946-1954. PubMed ID: 34126084
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blood-brain barrier function in response to SARS-CoV-2 and its spike protein.
    Suprewicz Ł; Fiedoruk K; Czarnowska A; Sadowski M; Strzelecka A; Galie PA; Janmey PA; Kułakowska A; Bucki R
    Neurol Neurochir Pol; 2023; 57(1):14-25. PubMed ID: 36810757
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuroinvasion of severe acute respiratory syndrome corona virus-2 (SARS-CoV-2): future risk of epilepsy.
    Kumar H; Gupta R
    Int J Neurosci; 2024 Apr; 134(4):323-332. PubMed ID: 35815479
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Possible mechanism of central nervous system targeting and neurological symptoms of the new-coronavirus (COVID-19): literature review.
    Jumagaliyeva M; Ayaganov D; Saparbayev S; Tuychibaeva N; Abdelazim IA; Kurmambayev Y; Khamidullina Z; Yessenamanova S
    Eur Rev Med Pharmacol Sci; 2023 Oct; 27(19):9420-9428. PubMed ID: 37843354
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Brain Renin-Angiotensin System: From Physiology to Pathology in Neuronal Complications Induced by SARS-CoV-2.
    Ahmadi S; Khaledi S
    Anal Cell Pathol (Amst); 2023; 2023():8883492. PubMed ID: 37575318
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-SARS-CoV-2 antibodies in the CSF, blood-brain barrier dysfunction, and neurological outcome: Studies in 8 stuporous and comatose patients.
    Alexopoulos H; Magira E; Bitzogli K; Kafasi N; Vlachoyiannopoulos P; Tzioufas A; Kotanidou A; Dalakas MC
    Neurol Neuroimmunol Neuroinflamm; 2020 Nov; 7(6):. PubMed ID: 32978291
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Central nervous system as a target of novel coronavirus infections: Potential routes of entry and pathogenic mechanisms.
    Sharma S; Jagadeesh H; Saxena A; Chakravarthy H; Devanathan V
    J Biosci; 2021; 46(4):. PubMed ID: 34840148
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The blood-brain barrier is dysregulated in COVID-19 and serves as a CNS entry route for SARS-CoV-2.
    Krasemann S; Haferkamp U; Pfefferle S; Woo MS; Heinrich F; Schweizer M; Appelt-Menzel A; Cubukova A; Barenberg J; Leu J; Hartmann K; Thies E; Littau JL; Sepulveda-Falla D; Zhang L; Ton K; Liang Y; Matschke J; Ricklefs F; Sauvigny T; Sperhake J; Fitzek A; Gerhartl A; Brachner A; Geiger N; König EM; Bodem J; Franzenburg S; Franke A; Moese S; Müller FJ; Geisslinger G; Claussen C; Kannt A; Zaliani A; Gribbon P; Ondruschka B; Neuhaus W; Friese MA; Glatzel M; Pless O
    Stem Cell Reports; 2022 Feb; 17(2):307-320. PubMed ID: 35063125
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Specialized proresolving mediators in infection and lung injury.
    Sandhaus S; Swick AG
    Biofactors; 2021 Jan; 47(1):6-18. PubMed ID: 33249673
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SARS-CoV-2 Infection in the Central and Peripheral Nervous System-Associated Morbidities and Their Potential Mechanism.
    Karuppan MKM; Devadoss D; Nair M; Chand HS; Lakshmana MK
    Mol Neurobiol; 2021 Jun; 58(6):2465-2480. PubMed ID: 33439437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.